Evaluation of peritol in the management of allergic diseases of the skin.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003533:Cyproheptadine / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004485:Eczema / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D009020:Morphine / Q000037:antagonists & inhibitors; D010919:Placebos; D012702:Serotonin Antagonists; D012890:Sleep / Q000187:drug effects; D014581:Urticaria / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D010919:Placebos; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D009020:Morphine; D000109:Acetylcholine